Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

林亮羽 (Liang-Yu Lin)

林亮羽(Liang-Yu Lin)圖 Return Appointment First Appointment

[Profile]

  • Education
    • Ph.D, Institute of Pharmacology; National Yang Ming Chiao Tung University , Taipei, Taiwan,
    • MD, School of Medicine; Taipei Medical University, Taiwan,
  • Career and Experience
    Current Positions：
    • - Now, Attending physician, Division of Endocrinology & Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • - Now, Assistant Professor, Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    Experiences：
    • - , Visiting scholar, University of California Los Angeles, U.S.A.
  • Medical Expertise
    1. Diabetic vasculopathy, pancreatic neuroendocrine tumor
    2. Endocrinology and Diabetes
  • License
    Subspecialty of Endocrinology and Metabolism Taiwan Board of Internal Medicine Certificate Certified Diabetes Educator

[Publications]

通訊作者

  • Li-Hsin Chang, Ting-Ting Chang, Chia-Huei Chu, Chin-Chou Huang, Liang-Yu Lin. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus. Clinica Chimica Acta. [IF 5.0]

第一加通訊作者

  • Lin LY, Chang TT, Leu HB, Huang CC, Wu TC, Chou RH, Huang PH, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, *Chen JW. Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clin Res Cardio. 2024 April 30. [IF 5.0]

共同作者

  • Chang TT, Lin LY, Chen C, Chen JW. CCL4 contributes to aging related angiogenic insufficiency through activating oxidative stress and endothelial inflammation. Angiogenesis. 2024 April 15. [IF:9.8]
  • Chen C, Lin LY, Wu YW, Chen JW, Chang TT. CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease. Clin Immunol. 2024 Sep 24. [IF 4.5]
  •  Chang TT, Li YZ, Mo HW, Chen C, Lin LY, Chang CC, Chen JW. CCL7 is a novel target for endothelial dysfunction and vasculopathy in diabetes mellitus. Science Translational Medicine. 2024 Nov 4. [IF 15.8]
回到最上